US Patent 11802155 ILT-binding agents and methods of use thereof
Patent 11802155 was granted and assigned to NGM Biopharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11802155 ILT-binding agents and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
